Internal Medicine, Endocrinology, Diabetes, & Metabolism · Rio Piedras, PR
NPI
1144427758
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
Clinica de la Escuela de Medicina, Reparto Metropolitano Shopping, Ave. Americo Miranda
Rio Piedras, PR, 00921
Phone (787) 758-7910
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,652
52 services
Medicare patients, 2024
27
Average age 72
Drug cost, 2024
$4.0M
22,229 prescriptions
Company payments, 2025
$826
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rafael A Gonzalez-Rosario was code 99213 (office e&m - established), 46 times for 24 patients. In total Rafael A Gonzalez-Rosario billed 52 services in 3 codes, and Medicare paid $2,652.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 46 | 24 | $49.66 | $2,284 |
By year: 2022 $2,954 for 74 services; 2023 $3,005 for 65 services; 2024 $2,652 for 52 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rafael A Gonzalez-Rosario prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 2,912 prescriptions and refills. In total Rafael A Gonzalez-Rosario wrote 22,229 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 2,912 | 3,955 | 507 | $182K |
| Rosuvastatin Calcium Generic | 1,295 | 1,978 | 307 | $14K |
| Metformin Hcl Generic | 1,019 | 1,466 | 226 | $6,277 |
| Atorvastatin Calcium Generic | 905 | 1,338 | 216 | $7,223 |
| Gabapentin Generic | 758 | 993 | 161 | $7,621 |
| Losartan Potassium Generic | 625 | 931 | 152 | $5,433 |
| Jardiance Empagliflozin | 591 | 721 | 133 | $441K |
| Trulicity Dulaglutide | 560 | 591 | 85 | $584K |
| Amlodipine Besylate Generic | 547 | 834 | 138 | $2,666 |
| Farxiga Dapagliflozin Propanediol | 511 | 564 | 107 | $331K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 492 | 592 | 97 | $46K |
| Metoprolol Succinate Generic | 490 | 727 | 110 | $6,173 |
| Tradjenta Linagliptin | 441 | 501 | 93 | $265K |
| Levothyroxine Sodium Generic | 353 | 504 | 80 | $3,668 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 332 | 378 | 64 | $228K |
Brand drugs: 9,398 claims; generic drugs: 12,712 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rafael A Gonzalez-Rosario $826 ($826 in general payments such as food, travel and fees) from 6 companies. The largest payer was Medtronic, Inc. with $632.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.